Pacira Pharmaceuticals reported $50.81M in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acelrx Pharmaceuticals ACRX:US $ 8.69M 1.05M
Adamas Pharmaceuticals ADMS:US 29.15M 2.51M
Aerie Pharmaceuticals AERI:US $ 34.54M 1.94M
Amerisourcebergen ABC:US $ 913.41M 183.33M
Astellas Pharma 4503:JP 137.11B 4.16B
Biodelivery Sciences International BDSI:US $ 25.78M 1.98M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Cara Therapeutics CARA:US $ 5.65M 683K
Coherus Biosciences CHRS:US $ 40.34M 954K
Depomed DEPO:US $ 26.24M 18.5M
Endo International Ordinary Shares ENDP:US 170.93M 12.7M
Flexion Therapeutics FLXN:US $ 27.41M 189K
Heron Therapeutics HRTX:US $ 33.16M 8.35M
Horizon Pharma HZNP:US 355.2M 23.21M
Ironwood Pharmaceuticals IRWD:US $ 27.05M 710K
JAZZ PHA JAZZ:US 429.03M 168.52M
Johnson & Johnson JNJ:US $ 6.07B 641M
Lannett LCI:US $ 21.58M 3.94M
Ligand Pharmaceuticals LGND:US $ 14.71M 2.09M
Nektar Therapeutics NKTR:US $ 29.56M 2.12M
Omeros OMER:US $ 21.56M 3.51M
Pacira Pharmaceuticals PCRX:US $ 50.81M 2.29M
Perrigo Ordinary Shares PRGO:US 271.9M 3M
Pfizer PFE:US $ 2.79B 134M
Revance Therapeutics RVNC:US $ 49.01M 937K
Supernus Pharmaceuticals SUPN:US $ 69.54M 8.08M
Teva Pharmaceutical TEVA:IT 832M 16M
Xeris Pharmaceuticals Inc XERS:US $ 25.93M 6.85M
Xoma XOMA:US $ 3.93M 2.81M
Zoetis ZTS:US $ 495M 86M